Qualigen Therapeutics, Inc.

Biotechnology • Healthcare • Carlsbad, CA, United States • QLGN (NCM)

Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was founded in 1996 and is based in Carlsbad, California.

Stock Performance (90 Days)

Data through Dec 22, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation - Yahoo Finance

Yahoo Finance • Oct 23

Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy - Investing News Network

Investing News Network • Nov 16

Faraday Future Announced a Total Strategic Investment of $41 million in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) During its Annual 919 Event, for its Crypto Business Focusing on Three Growth Engines - Faraday Future

Faraday Future • Sep 21

Why Is Qualigen Therapeutics’ Stock Surging Nearly 300% Premarket? - Stocktwits

Stocktwits • Sep 22

Qualigen Therapeutics stock surges after BitGo partnership for crypto treasury - Investing.com

Investing.com • Oct 23

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Qualigen Therapeutics, Inc. had layoffs?

No layoff events have been recorded for Qualigen Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Qualigen Therapeutics, Inc. in?

Qualigen Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Qualigen Therapeutics, Inc. a publicly traded company?

Yes, Qualigen Therapeutics, Inc. is publicly traded under the ticker symbol QLGN on the NCM. The company has a market capitalization of approximately $0.01 billion.

Where is Qualigen Therapeutics, Inc. headquartered?

Qualigen Therapeutics, Inc. is headquartered in Carlsbad, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.